Shared Health Research and Innovation MS7 820 Sherbrook Street Winnipeg, MB R3A 1R9 Phone: (204) 926-7020 shresearch@sharedhealthmb.ca January 20, 2023 SH2022:104 REB: B2022:049 Project Title: Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device in Spinal Fusion - A Canadian, Multicenter, Post-Market Clinical Investigation Dear Dr. P. Dhaliwal, The Shared Health Approval Committee for Privacy, Impact and Access in Research has considered your request for the above project. Your request is approved for impact. The following documents were reviewed during the assessment of this project. Note that any changes to documentation listed below will require re-review by this committee. Document Name Research Application Research Application - Amendment Protocol Consent Form Consent Form Consent Form – COVID-19 Appendix Questionnaire Appendix Data Capture Sheet Master List Version and/or Date Signed 30-May-2022 Signed 29-Nov-2022 31 Oct 2021 November 16th, 2022 1.0 May 2022 May 2022 1.0 1.0 Approval is subject to the following stipulations: Notification by Shared Health Research and Innovation, in writing, that the project may open for services as outlined in the protocol and/or supporting documentation. Appropriate acknowledgement of Shared Health, the WRHA and/or affiliated organizations in any peer-reviewed publications resulting from this study is required. For any results that may have an impact on the health system, a summary of the final results for the study must be submitted to Shared Health Research and Innovation along with a copy of any peer-reviewed publications arising from the study. For any results where Shared Health has contributed significant information, appropriate interpretation and/or privacy review may be required prior to publication. Shared Health Research and Innovation must receive notification, in writing to SHReserach@sharedhealthmb.ca, at least thirty (30) calendar days in advance for intended publication in learned journals or thesis presentations; and at least ten (10) calendar days prior notice is require for every poster or oral presentation unless otherwise mutually agreed between Shared Health Research and Innovation and Principal Investigator. If there is an agreement/contract with stipulations regarding these conditions, the conditions within the agreement/contract will prevail. Shared Health Research and Innovation must receive notification, in writing, within thirty (30) calendar days of project closure and/or termination. A fully executed contract/agreement must be in place prior to the initiation of any study related activities, if applicable. A completed Request for Account Information Form must be submitted to Shared Health Research and Innovation prior to activation, if applicable. A copy of the UofM FAAF form is submitted to Shared Health Research and Innovation upon submission to the UofM ORS. All supplies required to provide the services outlined in the protocol and/or supporting documentation must be on hand prior to project initiation. The annual REB approval and study status report is submitted to Shared Health Research and Innovation as it is received each year for the duration of the active study period. All members of the research team have completed PHIA training, and will maintain this training, renewing it every 3 years from date of issue, as required. For any confirmed breech to privacy, any costs incurred by Shared Health/WRHA for the investigation and/or ratification of the breech will be at the expense of the researcher. Shared Health reserves to cancel and/or suspend services without notice based on availability to provide required services. All current Public Health measures/restrictions must be adhered to, including entering all health care facilities and/or program spaces. We look forward to working with you on your project. Sincerely, Laura Curtis on behalf of Dr. Paul Beaudin, MSc-SLP, PhD Director of Research and Innovation, Shared Health Chair, Approval Committee for Privacy, Impact and Access in Research, WRHA & Shared Health PB/lc